Peptide InjectionsAI
Emerging evidence

Bronchogen

Peptide therapy: benefits, side effects, cost and protocols

C18H30N4O9

446.5 g/mol / CID 11690869
C18H30N4O9

Bronchogen (Ala-Glu-Asp) is a short bioregulatory peptide targeting bronchial and lung tissue. Part of the Khavinson bioregulator peptide series, it is studied for its potential to normalize respiratory tract function and support lung health.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

FDA status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Emerging Evidence

Who Bronchogen is usually considered for

  • Bronchial tissue support
  • 4 preclinical studies
  • Respiratory function
  • 2 preclinical studies
  • Mucosal health
  • Age-related lung support
  • 3 preclinical studies
  • Primarily animal or early-phase data

How Bronchogen works

Short bioregulator peptide that interacts with DNA promoter regions in bronchial epithelial cells, potentially modulating gene expression related to mucosal defense and tissue repair.

Key studies

12 papers on PubMed / 7 human trials

  1. 01

    [ANTIINFLAMMATORY AND REGENERATIVE EFFECT OF PEPTIDE THERAPY IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY]

  2. 02

    Titova ON, Kuzubova NA, Lebedeva ES et al

    Ross Fiziol Zh Im I M Sechenova / Ross Fiziol Zh Im I M Sechenova / Animal

  3. 03

    Bronchogen peptide reduced lung inflammation and restored bronchial epithelium structure in COPD model

  4. 04

    Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology

  5. 05

    Kuzubova NA, Lebedeva ES, Dvorakovskaya IV et al

    Bull Exp Biol Med / Bull Exp Biol Med / Animal

  6. 06

    Tetrapeptide Bronchogen restored bronchial epithelium structure and reduced inflammation in COPD rats

  7. 07

    Short Exogenous Peptides Regulate Expression of CLE, KNOX1, and GRF Family Genes in Nicotiana tabacum

  8. 08

    Fedoreyeva LI, Dilovarova TA, Ashapkin VV et al

    In Vitro / Biochemistry (Mosc)

  9. 09

    Exogenous peptides regulate growth and differentiation genes in tobacco callus cultures

  10. 10

    Peptides tissue-specifically stimulate cell differentiation during their aging

Bronchogen compound data

C18H30N4O9
446.5 g/mol
11690869 ↗
(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-carboxy-butanoyl]amino]-3-carboxy-propanoyl]amino]-4-methyl-pentanoic acid

Bronchogen questions

What is BRONCHOGEN?

Bronchogen is a Khavinson bioregulator tripeptide (Ala-Glu-Asp) researched for bronchial and respiratory tissue support, particularly in age-related respiratory decline.

How does BRONCHOGEN work?

Short bioregulator peptide that interacts with DNA promoter regions in bronchial epithelial cells, potentially modulating gene expression related to mucosal defense and tissue repair.

Is BRONCHOGEN legal to buy?

BRONCHOGEN is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy BRONCHOGEN?

BRONCHOGEN is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does BRONCHOGEN belong to?

BRONCHOGEN is primarily classified as a tissue repair & healing peptide. Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.

What are the research benefits of BRONCHOGEN?

BRONCHOGEN has been studied for: Bronchial tissue support, Respiratory function, Mucosal health, Age-related lung support. Khavinson bioregulator; respiratory/bronchial tissue focus.

Bronchogen in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering Bronchogen?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz